Amarin Corp’s Volatile Stock: Challenges & Opportunities in Cardiovascular Pharma
Amarin Corporation PLC’s fluctuating stock and market challenges highlight the tough biotech landscape for cardiovascular therapies—can the firm turn innovation into sustained growth?
3 minutes to read



